Star Combo Pharma Ltd has released a press release.
S66 ASX Appendix 3B
Filed with ASX ·
On 6ix: 6ix.com/news/s66-asx-appendix-3b
6ix hasn’t read this filing yet.
Earlier from Star Combo Pharma
- Trading Halt
- Pause in Trading
- Half Yearly Report and Accounts
- 2019 AGM Chairman and CEO Presentation
- Inature Organic Care acquisition
Later from Star Combo Pharma
- Star Combo Completes $33.3m Placement at $0.68 per share
- Star Combo Acquisition of iNature Option not exercised
- Purchase of 65 Woodpark Road
- $11m Transformational Investment
- Appendix 4D Half Yearly Report
Follow Star Combo Pharma into a list and get an email when it puts out news.
Follow Star Combo Pharma